These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21211274)

  • 1. [Decision-making of treatment and relative problems about recurrent and drug-resistant gynecologic neoplasms].
    Xie X; Cheng XD
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):801-3. PubMed ID: 21211274
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for gynecologic cancers.
    Rahaman J; Steiner N; Hayes MP; Chuang L; Fishman D; Gretz Iii H
    Mt Sinai J Med; 2009 Dec; 76(6):577-88. PubMed ID: 20014427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment strategies of refractory gynecological cancer].
    Xiang Y; Sun JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):721-3. PubMed ID: 19087534
    [No Abstract]   [Full Text] [Related]  

  • 4. The management of recurrent ovarian cancer.
    Bukowski RM; Ozols RF; Markman M
    Semin Oncol; 2007 Apr; 34(2 Suppl 2):S1-15. PubMed ID: 17512352
    [No Abstract]   [Full Text] [Related]  

  • 5. Ovarian cancer: a focus on management of recurrent disease.
    Herzog TJ; Pothuri B
    Nat Clin Pract Oncol; 2006 Nov; 3(11):604-11. PubMed ID: 17080178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH
    Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of CA-125 in epithelial ovarian cancer patients during and after chemotherapy.
    Lukácskó I; Hernádi Z; Sápy T; Borsos A
    Acta Chir Hung; 1997; 36(1-4):213-4. PubMed ID: 9408350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytostatic polychemotherapy plans integrated into the multimodal treatment of malignant gynecologic neoplasms. III].
    Bild E; Dragomir D
    Rev Med Chir Soc Med Nat Iasi; 1991; 95(3-4):323-32. PubMed ID: 1823458
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ovarian cancer].
    Langmár Z; Csömör S; Németh M; Tomcsik Z; Joó JG
    Orv Hetil; 2011 Dec; 152(49):1977-84. PubMed ID: 22106167
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of chemotherapy in gynecologic cancer.
    Tropé C; Kristensen G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and treatment of recurrent epithelial ovarian carcinoma].
    Wu XF; Chen HZ; Han DF
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):664-6. PubMed ID: 14728851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.
    Grønlund B
    Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of serum CA(125) detection for predicting recurrence and prognosis in ovarian epithelial cancer].
    Wang XY; Ye J; Feng SW; Lü WG; Wan XY; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):813-6. PubMed ID: 21211277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ovarian cancer].
    Cianti C
    Clin Ter; 2002; 153(2):135-44. PubMed ID: 12078339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second-line chemotherapy and new drugs for ovarian carcinoma].
    Priolo D; Antonelli G; Calì S; Colina P; Giuffrida D; Malaponte E; Mattina M; Parisi A; Sambataro D; Vitale F; Ferraù F
    Clin Ter; 2001; 152(1):39-50. PubMed ID: 11382169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy for ovarian cancer--general review].
    Ochiai K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():517-21. PubMed ID: 15535299
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress in the management of gynecologic cancer: consensus summary statement.
    Cannistra SA; Bast RC; Berek JS; Bookman MA; Crum CP; DePriest PD; Garber JE; Koh WJ; Markman M; McGuire WP; Rose PG; Rowinsky EK; Rustin GJ; Skates SJ; Vasey PA; King L
    J Clin Oncol; 2003 May; 21(10 Suppl):129s-132s. PubMed ID: 12743127
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacotherapy in ovarian carcinoma].
    Pfisterer J; Du Bois A
    MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fine-needle aspiration in gynecologic oncology].
    Sevin BU; Saks M; Nadji M
    Gynakologe; 1986 Jun; 19(2):116-22. PubMed ID: 3732928
    [No Abstract]   [Full Text] [Related]  

  • 20. [Profiling of serum tumor markers in patients with epithelial ovarian carcinoma].
    Dong L; Li XP; Cui H; Wang JL; Wei LH; Zhao Y; Wang SJ; Wang Y; Sun XL; Liang XD; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):121-5. PubMed ID: 19570423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.